Standout Papers

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVE... 2014 2026 2018 2022 634
  1. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials (2015)
    C.E.M. Griffiths, Kristian Reich et al. The Lancet
  2. Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey (2014)
    Mark Lebwohl, H. Bachelez et al. Journal of the American Academy of Dermatology
  3. A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis (2016)
    Kim Papp, Kristian Reich et al. British Journal of Dermatology
  4. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis (2021)
    Thomas Bieber, Eric L. Simpson et al. New England Journal of Medicine
  5. Bimekizumab versus Secukinumab in Plaque Psoriasis (2021)
    Kristian Reich, Richard B. Warren et al. New England Journal of Medicine
  6. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial (2022)
    Bruce Strober, Diamant Thaçi et al. Journal of the American Academy of Dermatology

Immediate Impact

2 by Nobel laureates 19 from Science/Nature 80 standout
Sub-graph 1 of 16

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system
2024 Standout
7 intermediate papers

Works of C. Paul being referenced

Bimekizumab versus Secukinumab in Plaque Psoriasis
2021 Standout
Efficacy of Psoralen UV‐A therapy vs. Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review
2012
and 4 more

Author Peers

Author Last Decade Papers Cites
C. Paul 8425 8430 2662 2895 409 15.9k
Joel M. Gelfand 8901 13768 1950 4978 277 20.9k
A.Y. Finlay 14495 6491 4423 2263 269 21.5k
P.C.M. van de Kerkhof 7810 8645 963 1780 495 15.4k
L. Puig 7372 10766 1068 3649 617 17.5k
Lone Skov 5292 6396 1666 1816 383 12.4k
Giampiero Girolomoni 9588 12086 3720 3699 539 23.0k
Robert Bissonnette 6798 4469 2677 2135 300 10.9k
Richard G. Langley 9354 14165 1139 3341 255 18.4k
Enno Christophers 5808 9842 2001 1904 357 18.5k
Wolf‐­Henning Boehncke 4271 8415 911 2658 355 12.9k

All Works

Loading papers...

Rankless by CCL
2026